Wolfgang Hiddemann – författare & böcker

Handbook of Acute Leukemia

Häftad, Engelska, 2016

565 kr

Skickas inom 10-15 vardagar

This book provides an overview of the key developments in both acute lymphocytic leukemia and acute myeloid leukemia with a comprehensive guide to the epidemiology, pathogenesis, etiology, clinical manifestations, classification, diagnosis, and staging as well as the most recent developments in the therapeutic landscape for acute leukemia. The Handbook of Acute Leukemia offers readers a key resource into the future outlook for patients with leukemia and is edited and authored by internationally renowned experts in the field. Leukemia is cancer of the white blood cells and acute leukemia means the condition progresses rapidly and aggressively, requiring immediate treatment. Acute leukemia is classified according to the type of white blood cells that are affected: either lymphocytes and myeloid cells.

Handbook of Acute Leukemia

AvWolfgang Hiddemann

E-bok

PDF, Engelska, 2016

708 kr

Läs direkt efter köp

This book provides an overview of the key developments in both acute lymphocytic leukemia and acute myeloid leukemia with a comprehensive guide to the epidemiology, pathogenesis, etiology, clinical manifestations, classification, diagnosis, and staging as well as the most recent developments in the therapeutic landscape for acute leukemia. The Handbook of Acute Leukemia offers readers a key resource into the future outlook for patients with leukemia and is edited and authored by internationally renowned experts in the field. Leukemia is cancer of the white blood cells and acute leukemia means the condition progresses rapidly and aggressively, requiring immediate treatment. Acute leukemia is classified according to the type of white blood cells that are affected: either lymphocytes and myeloid cells.

Tumor Aneuploidy

AvThomas Büchner,Clara D. Bloomfieldm. fl.

Häftad, Engelska, 1985

565 kr

Skickas inom 10-15 vardagar

Chromosome abnormalities of cancer cells have been recognized for a long time, and have generally proven to be a highly specific marker ofmalignancy. The contri- butions collected in this book, "Tumor Aneuploidy", cover several major aspects of present knowledge conceming the occurrence and clinical significance of chromo- some abnormalities as delineated by karyotype analyses or measurements of the cellular DNA content. Certain non-random clonal chromosome losses, deletions and translocations ap- pear to represent primary genetic lesions of malignancies and reflect their clonal origin. Secondary intraneoplastic genetic evolution is suggested by major clonal ab- normalities of chromosome number and cellular DNA content. Both types of ge- netic changes have been reaching great relevance in cancer medicine, today. Although the Philadelphia chromosome was first discovered in chronic myelo- cytic leukemia (CML), by Nowell and Hungerford in 1960, new banding techniques developed in the 1970's were needed to identity this abnormality as a translocation between chromosomes 9 and 22 (t(9; 22)).Soon thereafter, further non-random translocations were detected and attributed to special diseases like t(8; 21) and t(15; 17) to acute myeloid leukemias (AML) and t(9; 22), t(4; 11), t(8; 14) to acute lymphoblastic leukemia (ALL).

Del 33 - Haematology and Blood Transfusion Hämatologie und Bluttransfusion

Acute Leukemias II

Prognostic Factors and Treatment Strategies

AvThomas Büchner,Günther Schellongm. fl.

Häftad, Engelska, 1990

1 123 kr

Skickas inom 10-15 vardagar

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Die Onkologie

Teil 1: Epidemiologie - Pathogenese - Grundprinzipien der Therapie; Teil 2: Solide Tumoren - Lymphome - Leukämien

AvClaus R. Bartram,Wolfgang Hiddemann

E-bok

PDF, Tyska, 2009

2 115 kr

Läs direkt efter köp

Neu aufgelegt und aktualisiert – „Die Onkologie" in der 2. Auflage

Wie schon in der 1. Auflage präsentieren angesehene Experten aus Klinik, Praxis und Forschung das komplette klinisch-onkologische Wissen, basierend auf aktuell gesicherten wissenschaftlichen Erkenntnissen.

Fundiert aufbereitet, anschaulich und einprägsam dargestellt, bietet das Werk alles Notwendige zum Lernen, Nachschlagen und Anwenden in der Praxis. Durch die übersichtliche Struktur sind sämtliche relevanten Informationen schnell zu finden.

Band I: Klinisches Grundlagenwissen zu Epidemiologie, Pathogenese und Grundprinzipien der Therapie

Band II: Umsetzbare Empfehlungen zu Diagnostik und Therapie aller internistisch relevanten soliden Tumoren und malignen Systemerkrankungen

Acute Leukemias IX

Basic Research, Experimental Approaches and Novel Therapies

AvM. Unterhalt,J. Ritterm. fl.

E-bok

PDF, Engelska, 2012

1 132 kr

Läs direkt efter köp

Acute Leukemias IX provides an extended and thorough overview of recent developments in cell biology and experimental therapy for acute leukemias. Following the tradition of the Acute Leukemias series since 1987, this book bridges the gap between basic research and clinical studies and emphasizes that both aspects are equally necessary to achieve improvements, not only in understanding the disease but also in providing better therapy. As a forum for world-wide activities in the field of acute leukemias the volume contains invaluable contributions that provide the reader with new, previously unpublished information.

Acute Leukemias VI

Prognostic Factors and Treatment Strategies

AvUrsula Creutzig,Jorg Ritterm. fl.

E-bok

PDF, Engelska, 2012

2 036 kr

Läs direkt efter köp

Acute Leukemias VI

Prognostic Factors and Treatment Strategies

AvThomas Büchner,Wolfgang Hiddemannm. fl.

Häftad, Engelska, 2011

1 681 kr

Skickas inom 10-15 vardagar

The 6th volume of the book series Acute Leukemias presents both therapeutic and prognostic updates of the most recent results of major multicenter clinical trials. Additional chapters report on new trends in leucemia cell biology, the monitoring of minimal residual disease and secondary leucemias as well as new antileucemic drugs, antimicrobial strategies and the use of cytocines. Acute Leukemias VI provides a new update on the rapid progress being made internationally concerning leucemic diseases.

Acute Leukemias VII

Experimental Approaches and Novel Therapies

AvWilliam Plunkett,Ursula Creutzigm. fl.

E-bok

PDF, Engelska, 2012

1 132 kr

Läs direkt efter köp

The 7th volume of the book series Acute Leukemias provides new updates on the biology of acute leukemias and especially the underlying genetic and molecular events. High quality contributions are provided by leading scientists and clinicians making the book an excellent overview over most recent achievements which translate into new treatment strategies and hence an improved outlook for patients suffering from acute leukemias.

Acute Leukemias II

Prognostic Factors and Treatment Strategies

AvJorg Ritter,Wolfgang Hiddemannm. fl.

E-bok

PDF, Engelska, 2012

1 408 kr

Läs direkt efter köp

Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Acute Leukemias V

Experimental Approaches and Management of Refractory Disease

AvMichael J. Keating,William Plunkettm. fl.

E-bok

PDF, Engelska, 2013

708 kr

Läs direkt efter köp

150 years after the first description of the clinical picture of "white blood" and the introduction of the term "leukemia" by R. Virchow it appears, that the leukemias, and the acute leukemias in particular, serve as an impressive example for the major improvements that have been achieved in the treatment but also in the understand ing of the biology of malignant dis orders. The international symposia "Acute Leukemia" which are held at Münster since 1986 have developed into an interna tional forum to review the current progress and the future perspectives of leukemia research and therapy at a high scientific and clinicallevel. Since the possibility for active participation in these symposia is somewhat restricted we are glad to have the opportunity to extend the information that was presented at the symposium "Acute Leukemias V - Experimental Approaches and Management of Refractory Disease" which was held from February 27 to March 2, 1994 to a broader audience of basic scientists and clinicians. This meeting was especiaIly designed to discuss experimen tal approaches and the management of refractory disease which allows to evaluate new experimental therapies on the basis of preclinical studies.

Del 37 - Haematology and Blood Transfusion Hämatologie und Bluttransfusion

Acute Leukemias V

Experimental Approaches and Management of Refractory Disease

AvWolfgang Hiddemann,Thomas Büchnerm. fl.

Häftad, Engelska, 2012

565 kr

Skickas inom 10-15 vardagar

150 years after the first description of the clinical picture of "white blood" and the introduction of the term "leukemia" by R. Virchow it appears, that the leukemias, and the acute leukemias in particular, serve as an impressive example for the major improvements that have been achieved in the treatment but also in the understand ing of the biology of malignant dis orders. The international symposia "Acute Leukemia" which are held at Münster since 1986 have developed into an interna tional forum to review the current progress and the future perspectives of leukemia research and therapy at a high scientific and clinicallevel. Since the possibility for active participation in these symposia is somewhat restricted we are glad to have the opportunity to extend the information that was presented at the symposium "Acute Leukemias V - Experimental Approaches and Management of Refractory Disease" which was held from February 27 to March 2, 1994 to a broader audience of basic scientists and clinicians. This meeting was especiaIly designed to discuss experimen tal approaches and the management of refractory disease which allows to evaluate new experimental therapies on the basis of preclinical studies.

Die Onkologie

Teil 1: Epidemiologie - Pathogenese - Grundprinzipien der Therapie; Teil 2: Solide Tumoren - Lymphome - Leukämien

AvH. Huber,Claus R. Bartramm. fl.

E-bok

PDF, Tyska, 2013

535 kr

Läs direkt efter köp

Die gesamte Onkologie – verlässliches Wissen für Ihre Kompetenz!

"Die Onkologie" stellt sich der Herausforderung, das ständig wachsende Wissen über Tumorerkrankungen in seiner Gesamtheit zu vermitteln.

Sowohl inhaltlich als auch didaktisch auf höchstem Niveau:

Fundiertes Grundlagenwissen zum umfassenden Nachschlagen

Praxisrelevantes Know-how für Diagnostik und Therapie

Systematischer Aufbau für das Verständnis der komplexen Zusammenhänge

Angesehene Experten aus Klinik, Forschung und Praxis liefern Ihnen in

Teil1

Klinisches Grundlagenwissen zu den Grundprinzipien der Therapie, Epidemiologie, Ätiologie und Pathogenese, sowie zu Komplikationen des malignen Wachstums.

Teil 2

enthält umsetzbare und aktuelle Empfehlungen zu Diagnostik und Therapie aller relevanten soliden Tumoren und malignen Systemerkrankungen.

Zum Nachschlagen und Anwenden:

Finden Sie alle Optionen - auch für Ihren schwierigsten Fall.

Der übersichtliche Aufbau und die exzellenten Abbildungen erleichtern Ihnen das schnelle Auffinden und Verständnis der gesuchten Informationen.

Für den Alltag onkologisch tätiger Ärzte ist Die Onkologie ein unentbehrlicher Meilenstein.

Företag, bibliotek eller offentlig verksamhet?

Wolfgang Hiddemann – författare

Handbook of Acute Leukemia

Handbook of Acute Leukemia

Tumor Aneuploidy

Acute Leukemias II

Die Onkologie

Acute Leukemias IX

Acute Leukemias VI

Acute Leukemias VI

Acute Leukemias VII

Acute Leukemias II

Acute Leukemias V

Acute Leukemias V

Die Onkologie

Mina sidor

Mina sidor

Hjälp

Hjälp

Om Bokus

Om Bokus

Populärt

Populärt

Inspiration

Inspiration